Pharmacognostical And Phyto Analytical Studies On Musali Khadiradi Choornam – An Ayurvedic Formulation For The Treatment Of Uterine Disorders

Abstract

Musali khadiradi choornam (MKC) is prescribed by Ayurvedic physicians for the treatment of menorrhagia, leucorrhea, and polycystic ovaries syndrome (PCOS). The choornam contains six herbal drugs, they are Musali (Curculigo orchioides), Khadira (Acacia catechu), Amalaki (Emblica officinalis), Jambu (Syzygium cumini), Shatavari (Asparagus racemosus), and Trikanta (Tribulus terrestris). Various studies conducted by the National Institute of Health, Government of India, reveal that the prevalence of infertility among women with PCOS ranges from 70%-80%, and 60% of women aged 25-34 are affected by PCOS. The present study aims to evaluate the under-explored Ayurvedic formulation, “Musali khadiradi choornam” on its pharmacognostic and Phyto-analytical aspects as a step towards developing Pharmacopoeial standards. The morphological and powder microscopical observation helps authenticate the raw drugs and their formulation from adulterant in the market. The phytochemical screening including GC-MS studies brings out the drug on par with modern drug in the global markets. This study might be helpful for authentication of the formulation and making it available with global standards.